EMPACT: Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy (clinicaltrials.gov) - Jun 19, 2026 - P4 | N=68 | Recruiting | Sponsor: Seoul St. Mary's Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiac Amyloidosis • Cardiomyopathy • Cardiovascular
|